A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.
about
Five years of GWAS discoveryMaturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?Undiagnosed MODY: Time for ActionMetabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkersUse of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studiesLess but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level.Low serum level of high-sensitivity C-reactive protein in a Japanese patient with maturity-onset diabetes of the young type 3 (MODY3).Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.Genomic prediction of complex human traits: relatedness, trait architecture and predictive meta-models.Multiple inflammatory biomarker detection in a prospective cohort study: a cross-validation between well-established single-biomarker techniques and an electrochemiluminescense-based multi-array platformClinical features and treatment of maturity onset diabetes of the young (MODY).Using highly sensitive C-reactive protein measurement to diagnose MODY in a family with suspected type 2 diabetesLower Frequency of HLA-DRB1 Type 1 Diabetes Risk Alleles in Pediatric Patients with MODY.Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.Mutations in HNF1A result in marked alterations of plasma glycan profileWhen to consider a diagnosis of MODY at the presentation of diabetes: aetiology matters for correct management.Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors.Effects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications.The role of pancreatic imaging in monogenic diabetes mellitus.When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes.Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.RD Lawrence lecture 2012: assessing aetiology in diabetes: how C-peptide, CRP and fucosylation came to the party!Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860–1862.Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry.High Prevalence of Diabetes-Predisposing Variants in MODY Genes Among Danish Women With Gestational Diabetes Mellitus.The spectrum of HNF1A gene mutations in Greek patients with MODY3: relative frequency and identification of seven novel germline mutations.Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives.Hidden MODY-Looking for a Needle in a Haystack.HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties
P2860
Q24610574-32F05002-FEB3-4076-AC74-2C13EEF8DC88Q26771916-9A465848-C2FD-4DBA-AA13-EEF8DEC6D003Q28083025-C5D91187-6D84-4FA1-8034-A03FB990F3B3Q28481662-15C5E2AB-F141-4896-816A-6C48F3B9CAE9Q31120060-1106A4B6-3295-4354-A0C7-D6480AC8FBE0Q34023089-4ED94016-8D3C-4BFA-BC08-291421F9DE45Q34299618-21B98C45-0DA8-4FF1-B5E8-8D6286383E67Q34322165-2A9521FF-F164-4F0F-80B9-8E5CFDD6958EQ34473904-4D73FADF-A85D-4BB9-9F9C-BE81E94FCCB7Q34615040-2697AA1B-F7EF-45BD-A938-E642D274A86FQ35997281-56278EA3-B4AC-4528-9B05-8AEF3FEBE053Q36157483-B0EB4EFB-73FA-4EA2-8B1D-84601776B4F1Q36239494-02B962DA-EFAF-46A3-BA9D-DD0B41588819Q36327109-2F164D03-F825-417C-A5CD-00713FBEC984Q36720490-EA821E6C-34C7-4BD2-B0A5-8AAAFD2A1B03Q36912662-577675DC-EF84-48DE-994F-B2D4938A9DCCQ36990179-7575E3C7-02FB-442B-94A3-6E11E82F2C30Q37000827-A3713C1C-1D18-47A3-B68D-3F97B95737D7Q37403160-2C738F26-C3E2-47BD-AB5B-EFBBDE6D193EQ37962349-BACB557A-A900-418E-B477-9BE83730B991Q38816600-5487EC87-D653-40E2-BC61-04DC6C31E1FDQ39079275-E0E69C19-FA75-4824-951E-5CBD9EE1456BQ41020576-3248E9A0-727C-4ED7-98CD-BA91785EB102Q43538580-0668F9B0-8448-4C23-B01B-0DE8A61C4026Q45905297-0F9A7527-14B0-4BFC-AE94-12B72BC8365EQ49885981-03D6E6CF-4F91-4389-B85A-4D972285F647Q51287966-B85F9276-38B6-406C-BC81-02B2BB4572A2Q52741473-0BF1048B-CB67-4ADB-8A71-F146C47C7695Q54267275-42C0FDF5-6827-4101-940F-693CF01E1CCCQ54973025-49C1F193-22D8-4C73-8AC8-017B321ED1B3Q55715140-3D418A75-6E77-4E70-9FCE-BFA6A135BF0AQ56530315-53A17405-45AF-4F25-A8C3-DF32AE1F866A
P2860
A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A large multi-centre European ...... iagnosis of diabetes subtypes.
@ast
A large multi-centre European ...... iagnosis of diabetes subtypes.
@en
A large multi-centre European study validates high-sensitivity C-reactive protein
@nl
type
label
A large multi-centre European ...... iagnosis of diabetes subtypes.
@ast
A large multi-centre European ...... iagnosis of diabetes subtypes.
@en
A large multi-centre European study validates high-sensitivity C-reactive protein
@nl
prefLabel
A large multi-centre European ...... iagnosis of diabetes subtypes.
@ast
A large multi-centre European ...... iagnosis of diabetes subtypes.
@en
A large multi-centre European study validates high-sensitivity C-reactive protein
@nl
P2093
P2860
P50
P1433
P1476
A large multi-centre European ...... diagnosis of diabetes subtypes
@en
P2093
D Gašperíková
E Andersson
F Loiseleur
G Thanabalasingham
P2860
P2888
P304
P356
10.1007/S00125-011-2261-Y
P577
2011-08-04T00:00:00Z
P5875
P6179
1011071763